U.S. markets closed
  • S&P Futures

    4,260.75
    +6.00 (+0.14%)
     
  • Dow Futures

    34,396.00
    +15.00 (+0.04%)
     
  • Nasdaq Futures

    14,150.50
    +25.75 (+0.18%)
     
  • Russell 2000 Futures

    2,324.40
    +0.80 (+0.03%)
     
  • Crude Oil

    71.34
    +0.46 (+0.65%)
     
  • Gold

    1,863.00
    -2.90 (-0.16%)
     
  • Silver

    27.75
    -0.28 (-1.01%)
     
  • EUR/USD

    1.2120
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.5010
    +0.0390 (+2.67%)
     
  • Vix

    16.39
    +0.74 (+4.73%)
     
  • GBP/USD

    1.4105
    -0.0003 (-0.02%)
     
  • USD/JPY

    110.0680
    +0.0070 (+0.01%)
     
  • BTC-USD

    40,146.24
    +451.29 (+1.14%)
     
  • CMC Crypto 200

    1,004.69
    +35.85 (+3.70%)
     
  • FTSE 100

    7,146.68
    +12.62 (+0.18%)
     
  • Nikkei 225

    29,439.09
    +277.29 (+0.95%)
     

Orphazyme stock's rocket ride leads to 20 volatility halts, Galecto stock halted 7 times

·1 min read
Orphazyme stock's rocket ride leads to 20 volatility halts, Galecto stock halted 7 times
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Orphazyme A/S blasted 383.8% higher, enough to make the Denmark-based biopharmaceutical company's stock by far the biggest gainer listed on major U.S. exchanges, prior to a trading halt. The stock, which was up as much as 1,387% at its intraday high of $77.77, was halted for volatility for the 20th time Thursday at 3:24 p.m. Eastern with the last trade at $25.30, and remains halted. The stock's rally gave the company a market capitalization of $884.3 million. The company confirmed that